MedPage Today

Rare Childhood Disorder Gets Its First FDA Drug Approval

The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency ...

FDA commissioner explains new food pyramid, encourages greater uptake of core childhood vaccines

Martin Makary, commissioner of the Food and Drug Administration, on the push against ultra processed foods and added sugar, ...

Travere shares fall as US FDA extends review of rare kidney disease drug

The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a ...
GlobalData on MSN

FDA increases manufacturing flexibility for cell and gene therapies

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Study Finds FDA Used Evidence, Not Politics, in Abortion Pill Decisions

Internal FDA reviews examined in the JAMA study show that the agency repeatedly confirmed that mifepristone is safe. One ...

FDA Recalls Modern Warrior Ready Supplement For Hidden, Dangerous Ingredients

A dietary supplement has been recalled after testing revealed undeclared ingredients that could cause life-threatening health ...

US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease

The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug ​for children ...
STAT

Watch: At JPM, former drug regulator Richard Pazdur rings the alarm about politics at FDA

Here's full footage from a STAT event with former top FDA official Richard Pazdur, who expressed grave concern about ...